Loading…
Operator of senior living communities providing independent living, assisted living and memory care across the US.
Operator of senior living communities providing independent living, assisted living and memory care across the US.
Residents pay monthly fees that combine rent and a care charge rising with the help they need, mostly out of their own pocket or through long-term-care insurance rather than Medicare, so occupancy and annual rate increases drive results. It was named Capital Senior Living until 2021.
Moat: none (scale). Mid-size senior-living operator competing in a fragmented industry against larger, better-capitalized chains.
Headquarters: Plano, Texas · Founded: 1985 · Employees: 5,140
Size Sonida Senior Living (SNDA) is a United States Health Care company (Medical/Nursing Services) with a market value of $1.58B, the 1955th largest of 3,117 United States companies the cockpit tracks. Shares closed at $32.78 on 6 Nov 2026.
Performance Over six months the shares fell 14.3%, against +21.3% for the median peer and -1.1% for the United States market (cap-weighted) — 4th lowest of 21 in its peer set.
Growth Revenue grew 49.4% over the last twelve months (peer median +5.9%); the operating margin is -10.7% (peer median 4.7%).
Valuation It trades at 5.9× enterprise value to sales against a peer median of 2.1× (5th most expensive of 21).
Capital Return on invested capital runs 9.2 points below its cost of capital (7.3% WACC).
Short interest Short interest is 8.0% of the free float (15 Oct 2026).
Next results Next results expected around 31 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $526M | $381M | $304M | $255M | $238M |
| Revenue growth | — | +25% | +19% | +7% | — |
| Gross profit | $33.5M | $26.4M | $25.2M | $38.1M | $28.4M |
| EBITDA | $36.4M | $26.0M | $25.3M | $21.7M | $9.14M |
| Net income | -$122M | -$70.8M | -$2.06M | -$21.1M | -$54.4M |
| Free cash flow | -$52.7M | -$8.92M | -$27.0M | -$7.25M | -$38.5M |
| Capital expenditure | $37.1M | $33.3M | $25.2M | $17.9M | $36.9M |
| Total debt | $1.57B | $690M | $651M | $629M | $671M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g |
|---|---|---|---|---|---|---|
| Sonida Senior Living SNDA | $1.58B | -14% | +49% | -11% | 5.9× | n/a |
| Brookdale Senior Living BKD | $2.15B | -31% | -4% | 5% | 2.4× | 22.4% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | SNDA | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -8.8% | +7.8% | 2nd lowest of 21 |
| 6-month return | -14.3% | +21.3% | 4th lowest of 21 |
| Distance from 52-week high | -26.1% | -16.0% | 8th lowest of 21 |
| Revenue growth (TTM) | +49.4% | +5.9% | highest of 21 |
| Operating margin | -10.7% | 4.7% | 4th lowest of 21 |
| EV / Sales | 5.9× | 2.1× | 5th most expensive of 21 |
| ROIC minus cost of capital | -9.2 pp | -3.7 pp | 6th lowest of 20 |
| EV / EBITDA | 84.7× | 21.1× | most expensive of 14 |
| Net debt / EBITDA | 41.3× | 1.6× | most indebted of 15 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Sonida Senior Living SNDA | United States | $1.58B | -14% | +49% | -11% | 5.9× | n/a | n/a |
| Teladoc Health TDOC | United States | $1.60B | +21% | -2% | -5% | 0.7× | -5.2% | +18.3% |
| Vijaya Diagnostic Centre VIJAYA.NS | India | $1.60B | +22% | +24% | 32% | 16.8× | 39.3% | +16.7% |
| Ambea AMBEA.ST | Sweden | $1.63B | +30% | +13% | 8% | 1.7× | 1.7% | +7.7% |
| Ping An Healthcare and Technology 1833.HK | Hong Kong | $1.63B | -47% | +8% | 3% | 0.7× | 15.0% | -5.1% |
| U.S. Physical Therapy USPH | United States | $1.48B | +68% | +11% | 10% | 2.7× | 19.9% | +13.0% |
| Personalis PSNL | United States | $1.71B | +164% | -13% | -164% | 22.1× | n/a | n/a |
| Azenta AZTA | United States | $1.72B | +104% | +1% | -3% | 2.4× | 56.0% | +8.9% |
| Dr. Agarwal's Health Care AGARWALEYE.NS | India | $1.74B | +15% | +22% | 15% | 7.4× | 41.9% | +26.9% |
| Clariane CLARI.PA | France | $1.40B | -20% | +1% | 6% | 1.6× | 6.7% | +6.5% |
| H.U.Group 4544.T | Japan | $1.35B | +24% | +1% | 2% | 0.9× | 10.1% | +2.1% |
| GeneDx WGS | United States | $1.86B | +53% | +25% | -12% | 4.2× | n/a | n/a |
| agilon health AGL | United States | $1.90B | +109% | 0% | -4% | 0.3× | n/a | n/a |
| Diagnostyka DIA.WA | Poland | $1.29B | -5% | +19% | 15% | 2.4× | 6.9% | +18.9% |
| OPKO Health OPK | United States | $1.29B | +52% | -11% | -29% | 2.4× | n/a | n/a |
| Lumexa Imaging LMRI | United States | $1.29B | +29% | +8% | 3% | 2.1× | n/a | n/a |
| Emeis EMEIS.PA | France | $1.94B | -30% | +4% | 3% | 1.6× | 21.3% | +8.5% |
| Pennant PNTG | United States | $1.27B | +1% | +38% | 6% | 1.6× | 21.1% | +19.4% |
| Dian Diagnostics 300244.SZ | China | $1.97B | +11% | -5% | 9% | 1.5× | 2.4% | -1.1% |
| Metropolis Healthcare METROPOLIS.NS | India | $1.25B | +12% | +20% | 18% | 6.6× | 32.4% | +10.5% |
| Guangzhou Kingmed Diagnostics 603882.SS | China | $1.99B | +5% | -3% | 7% | 2.0× | 6.7% | -6.1% |